Autoantibodies in the grocery shop: Does quantity matter?

Immunologic Research

Volumn 56, Issue 2-3, 2013, Pages 413-419

  Damoiseaux, Jan ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoantibody; Autoimmune disease; Diagnosis; Prediction

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CHOLINERGIC RECEPTOR; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT FACTOR; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN A; LA ANTIBODY; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; RAPSYN; RIBONUCLEOPROTEIN ANTIBODY;

ANCA ASSOCIATED VASCULITIS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTICOAGULANT THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; FALSE POSITIVE RESULT; FOLLOW UP; GLOMERULUS BASEMENT MEMBRANE; GLUTEN FREE DIET; GOODPASTURE SYNDROME; GRANULOMATOSIS; HEMAGGLUTINATION; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; INTERNAL VALIDITY; LIMIT OF DETECTION; MEDICAL SPECIALIST; MIXED CONNECTIVE TISSUE DISEASE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PLASMAPHERESIS; POSTSYNAPTIC MEMBRANE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RELAPSE; RHEUMATOID ARTHRITIS; STANDARDIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HUMANS; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE STANDARDS; SEROLOGIC TESTS;

EID: 84879554743     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8419-6     Document Type: Article

References (36)

1. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
2. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. European study group on classification criteria for Sjögren's syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:554-8. (Pubitemid 34539104)
3. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T. Sjögren's international collaborative clinical alliance (SICCA) research groups. American college of rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's international collaborative clinical alliance cohort. Arthritis Care Res. 2012;64:475-87.
4. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148-59.
5. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. J Rheumatol. 1989;16:328-34. (Pubitemid 19104571)
6. Kahn MF, Appelboom T. Syndrom de Sharp. In: Kahn MF, Peltier AP, Meyer O, Piette JC, editors. Les maladies systemiques. Paris: Flammarion; 1991. p. 545-56.
7. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyianopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
8. Tozzoli R, Bizzaro N. The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev. 2012;11:766-70.
9. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upschurch KS, Vencovský J, Wolfe F, Hawker G. Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8.
10. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Mäki M, Ribes-Koninckx C, Ventura A, Zimmer KP. For the ESPGHAN working group on celiac disease diagnosis, on behalf of the ESPGHAN gastroenterology committee. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of celiac disease. JPGN. 2012;54:136-60.
11. Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev. 2009;8:543-8.
12. Bossuyt X, Coenen D, Fieuws S, Verschueren P, Westhovens R, Blanckaert N. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor. Ann Rheum Dis. 2009;68:287-9.
13. Vermeersch P, Blockmans D, Bossuyt X. Use of likelihood ratios can improve the clinical usefulness of enzyme immunoassays for the diagnosis of small-vessel vasculitis. Clin Chem. 2009;55:1886-8.
14. Vermeersch P, Coenen D, Geboes K, Mariën G, Hiele M, Bossuyt X. Use of likelihood ratios improves clinical interpretation of IgA anti-tTG antibody testing for celiac disease. Clin Chim Acta. 2010;411:13-7.
15. Mahler M, Radice A, Sinico RA, Damoiseaux J, Seaman A, Buckmelter K, Vizjak A, Buchner C, Binder WL, Fritzler MJ, Cui Z. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant. 2012;27:243-52.
16. Farrugia ME, Vincent A. Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol. 2010;23:489-95.
17. Losen M, Stassen MH, Martinez-Martinez P, Machiels BM, Duimel H, Frederik P, Veldman H, Wokke JH, Spaans F, Vincent A, De Baets MH. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Brain. 2005;128:2327-37. (Pubitemid 41407973)
18. Sugai E, Nachman F, Väguez H, González A, Andrenacci P, Czech A, Niveloni S, Mazure R, Smecuol E, Cabanne A, Mauriño E, Bai JC. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis. 2010;42:352-8.
19. Zhong S, Qiu YF, Han BB, Zhao JY, Zhu XJ, Chen XX. Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris. Beijing Da Xue Xue Bao. 2011;43:414-5.
20. Kavanaugh AF, Solomon DH. The American college of rheumatology ad hoc committee on immunologic testing guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum. 2002;47:546-55. (Pubitemid 35291379)
21. Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus. 2004;13:290-7. (Pubitemid 38788485)
22. Birck R, Schmitt WH, Kaelsch IA, Van der Woude F. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis. 2006;47:15-23. (Pubitemid 41828262)
23. Tomasson G, Grayson PC, Mahr AD, LaValley M, Merkel PA. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis - a meta-analysis. Rheumatology. 2012;51:100-9.
24. Damoiseaux J, Austen J, Cohen Tervaert JW. ANCA diagnostics in clinical practice: new developments. In: Amezcua-Guerra LM, editor. Advances in the diagnosis and treatment of vasculitis. Rijeka: Intech; 2012. p. 3-18.
25. Boomsma MM, Damoiseaux J, Stegeman CA, Kallenberg CGM, Patnaik M, Peter JB, Cohen Tervaert JW. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods. 2003;274:27-35. (Pubitemid 36263040)
26. Damoiseaux J, Slot MC, Vaessen M, Stegeman CA, Van Paassen P, Cohen Tervaert JW. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis. J Clin Immunol. 2005;25:202-8. (Pubitemid 40884045)
27. Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, Cohen Tervaert JW. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA associated vasculitis and Goodpasture's disease. Ann NY Acad Sci. 2007;1109:454-63. (Pubitemid 47511388)
28. Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, Van Paassen P, Stöcker W, Schlumberger W, Cohen Tervaert JW. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis. 2009;68:228-33.
29. Kallenberg CGM, Stegeman CA, Bootsma H, Bijl M, Limburg PC. Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful? Lupus. 2006;15:397-402. (Pubitemid 44147083)
30. Radice A, Bianchi L, Sinico RA. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev. 2013;12:487-95.
31. Shoenfeld Y, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni PL, Piette J-C, Schmidt R, Wiik A. EASI - the European autoimmunity standardisation initiative. A new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann NY Acad Sci. 2007;1109:138-44. (Pubitemid 47511353)
32. Damoiseaux J, Cohen Tervaert JW, Derksen R, Hamann D, Hooijkaas H, Klasen I, Kallenberg C, Limburg P, Smeenk R. Autoantibody standardization in the Netherlands: the past, the present, and the future. Ann NY Acad Sci. 2009;1173:10-4.
33. Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab. 2010;95:25-33.
34. Roggenbuck D, Egerer K, Von Landenberg P, Hiemann R, Feist E, Burmester G-R, Dörner T. Antiphospholipid antibody profiling - time for a new technical approach? Autoimmun Rev. 2012;11:821-6.
35. Op De Beéck K, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D, Bossuyt X. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev. 2012;12:137-43.
36. Pengo V, Tripodi G, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society of thrombosis and haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost. 2009;7:1737-40.